[Prevention of recurrent hemorrhage caused by rupture of esophageal varices in cirrhotic patients].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004932:Esophageal and Gastric Varices / Q000150:complications*; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications; D011170:Portasystemic Shunt, Surgical; D012422:Rupture, Spontaneous; D012597:Sclerosing Solutions / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D012597:Sclerosing Solutions
Prévention de la récidive des hémorrgies par rupture de varices oesophagiennes chez les cirrhotiques.